Literature DB >> 32553970

Hirudin protects against isoproternol-induced myocardial infraction by alleviating oxidative via an Nrf2 dependent manner.

Haowen Zhang1, Hanyu Chen2, Jun Li3, Yaoyao Bian1, Yulei Song1, Zhenhui Li1, Feiyu He1, Siyi Liu1, Yun Tsai4.   

Abstract

Oxidative stress plays a critical role in the progression of myocardial injury. Increasing evidence suggests that hiruidin can treat patients with cardio-injury. However, the mechanism of hirudin against myocardial infraction remains unknown. In the present study, we evaluated the potential role and mechanism of hirudin on both isoproterenol (ISO)-induced myocardial infraction (MI) in rats and Hypoxia-Reoxygenation model in H9C2 cells. Compared with the model group, hirudin apparently decreased the levels of myocardial Creatine Kinase Isoenzyme-MB (CK-MB), lactate dehydrogenase (LDH), and alleviated myocardial histopathological changes induced by ISO injection. The underlying mechanisms were revealed by the following observations: Hirudin exerted its cardioprotective effect via restoring super oxide dismutase (SOD), attenuating reactive oxygen species (ROS) and malondialdehyde (MDA). It induced the activation of Nuclear factor erythroid 2-related factor 2 (Nrf2) signal pathway through disrupting Keap1-Nrf2 complex, thus Nrf2 translocated from cytoplasm to nucleus to regulate Nrf2-dependent gene (HO-1, SOD) expressions. Furthermore, it should be noted that hirudin restored mitochondrial membrane potential in addition to cytochrome C-related apoptosis.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Hirudin; Myocardial infarction; Nrf2; Oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 32553970     DOI: 10.1016/j.ijbiomac.2020.06.097

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  5 in total

1.  Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy.

Authors:  Mengnan Liu; Gang Luo; Li Dong; Maryam Mazhar; Li Wang; Wenlu He; Yan Liu; Qibiao Wu; Hua Zhou; Sijin Yang
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Comprehensive Transcriptome Sequencing Analysis of Hirudinaria manillensis in Different Growth Periods.

Authors:  Huiquan Shan; Ke Ren; Jiasheng Liu; Saif Ur Rehman; Xiuying Yan; Xiaocong Ma; Yalin Zheng; Tong Feng; Xiaobo Wang; Zhipeng Li; Weiguan Zhou; Chen Chuang; Mingkun Liang; Jinghui Zheng; Qingyou Liu
Journal:  Front Physiol       Date:  2022-05-25       Impact factor: 4.755

3.  Tanshinone I Inhibits Oxidative Stress-Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling.

Authors:  Yu-Ting Wu; Ling-Peng Xie; Yue Hua; Hong-Lin Xu; Guang-Hong Chen; Xin Han; Zhang-Bin Tan; Hui-Jie Fan; Hong-Mei Chen; Jun Li; Bin Liu; Ying-Chun Zhou
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 4.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 5.  Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review.

Authors:  Chen Junren; Xie Xiaofang; Zhang Huiqiong; Li Gangmin; Yin Yanpeng; Cao Xiaoyu; Gao Yuqing; Li Yanan; Zhang Yue; Peng Fu; Peng Cheng
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.